Improved Resection Rates in Locally Advanced Pancreatic Cancer Following Addition of Intratumoral NanoPac® to Standard of Care
Improved Resection Rates in Locally Advanced Pancreatic Cancer Following Addition of Intratumoral NanoPac® to Standard of Care Presentation of Single-Site Clinical Trial Data Analysis at ACG 2021 ...
NanOlogy Announces First Patient Enrollment in Lung Cancer Clinical Trial
NanOlogy Announces First Patient Enrollment in Lung Cancer Clinical Trial FT. WORTH, (April 27, 2021) — NanOlogy, LLC, a clinical-stage interventional oncology drug therapy company, ...
NanOlogy Completes Enrollment of Bladder Cancer Clinical Trial
NanOlogy Completes Enrollment of Bladder Cancer Clinical Trial FT. WORTH, (March 9, 2021) — NanOlogy, LLC, a clinical-stage oncology company, today announced that enrollment has been complete ...